Open AccessAssessment of Nuclear ZEB2 as a Biomarker for Colorectal Cancer Outcome and TNM Risk Stratification
Author(s) -
Rahul Sreekumar,
Scott Harris,
Karwan Moutasim,
Ricardo De Matos Simoes,
Ashish Patel,
Katherine Emo,
Sophie White,
Tamer Yağcı,
Eugene Tulchinsky,
Gareth J. Thomas,
John Primrose,
A. Emre Sayan,
Alex H. Mirnezami
Publication year - 2018
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2018.3115
Subject(s) - medicine , cohort , colorectal cancer , nomogram , oncology , prospective cohort study , biomarker , cohort study , cancer , biochemistry , chemistry
This diagnostic study investigates whether nuclear ZEB2 expression in colorectal cancer is associated with early recurrence and reduced survival in 2 independent patient cohorts.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom